Cargando…
Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study
BACKGROUND: Prior studies of the pharmacogenomics of osteonecrosis of the jaw (ONJ) have had various methodological limitations, including using candidate gene selection as their sole strategy, a small number of ONJ cases, or a study population based on an oncology setting. OBJECTIVES: The aim of ou...
Autores principales: | Pedersen, Alma B., Nørholt, Sven E., Rejnmark, Lars, Langdahl, Bente, Starch-Jensen, Thomas, Sørensen, Henrik T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792722/ https://www.ncbi.nlm.nih.gov/pubmed/36582190 http://dx.doi.org/10.1016/j.bonr.2022.101648 |
Ejemplares similares
-
Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
por: Taguchi, Akira, et al.
Publicado: (2017) -
Treatment of osteonecrosis of the jaw related to bisphosphonates
and other antiresorptive agents
por: Rodriguez-Lozano, Francisco-Javier, et al.
Publicado: (2016) -
Validity of an algorithm to identify osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Danish National Registry of Patients
por: Gammelager, Henrik, et al.
Publicado: (2013) -
Osteonecrosis of the jaw and survival of patients with cancer: a nationwide cohort study in Denmark
por: Corraini, Priscila, et al.
Publicado: (2017) -
Relationship between drug holiday of the antiresorptive agents and surgical outcome of medication-related osteonecrosis of the jaw in osteoporosis patients
por: Morishita, Kota, et al.
Publicado: (2022)